A review of the medical records of thousands of adolescents treated for obesity found that kids who received the GLP-1 ...
Retired Oak Ridge, Tennessee, physician notes the downside of a class of drugs − GLP-1s − first approved for treating ...
Chinese insulin maker Gan & Lee Pharmaceuticals is wading into the obesity world with an injectable GLP-1 agonist that beat Novo Nordisk's Ozempic (semaglutide) at lowering glycated hemoglobin (HbA1c) ...
GLP-1 agonists work by triggering the pancreas to produce more insulin, which reduces blood sugar levels in those with type 2 ...